In the acute phase of AD, decreased IFN-γ production by Th1 cells is insufficient to suppress Th2-mediated responses, contributing to allergic inflammation, elevated IgE levels, and skin barrier dysfunction [1,2]. The gene discussed is IFNG; the disease is Alzheimer disease.